Clin2
NCT07427797Likely a fitRecruiting

Study of a treatment for frown lines between the eyebrows

Moderate to Severe Glabellar Lines

Part of Skin clinical trials.

This study tests a new medicine (IPN10200) to see how well it works and how safe it is for reducing moderate to severe frown lines between the eyebrows in adults. If you are unhappy with the appearance of these lines, this trial may help.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
300 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have moderate to severe frown lines between your eyebrows that bother you.
  • You have not had any botulinum toxin (like Botox) treatment anywhere in your body in the past 9 months.
  • You have not had any facial surgery or cosmetic procedures (like fillers, laser, or skin resurfacing) on your upper face in the past 3 to 12 months.
  • You do not have any active skin infections or conditions like scars or tattoos near the treatment area.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07779252Not yet recruiting· Phase 3
Study of a new treatment for frown lines between the eyebrows

This study tests a new medication (IPN10200) to safely reduce moderate to severe frown lines between the eyebrows in adults. It may help if you are bothered by these lines and are looking for a non-surgical option.

NCT07435428Recruiting· Phase 3
Study of a new treatment for moderate to severe frown lines between eyebrows

This trial tests a new medication's effectiveness and safety over time in adults with moderate to severe frown lines between the eyebrows. It aims to see if the treatment can reduce these lines and improve satisfaction with appearance.

Los Angeles, California
NCT06937944Recruiting· Phase 3
New Botox-like injection for frown lines

This study tests a new botulinum toxin injection (similar to Botox) to see how well it smooths moderate to severe frown lines between the eyebrows. The treatment is given as a single injection and may help soften those lines for several months.

Beijing, Beijing Municipality
NCT07756580Not yet recruiting· Phase 1
Study of injections for frown lines between the eyebrows

This study tests two different injection treatments for moderate to severe frown lines between the eyebrows. It aims to find the best way to use these treatments to improve your appearance.

NCT06205797Recruiting· Phase 3
Study of a new treatment for frown lines between the eyebrows

This trial tests an injection called HU-045 to reduce moderate to severe frown lines. It may help adults who want to soften those vertical lines between the eyebrows.

Seoul
NCT07730554Recruiting· Phase 2
Study of injections for forehead and frown lines

This trial tests an injectable treatment for moderate to severe forehead lines and frown lines in adults. It aims to see if the injections can safely reduce the appearance of these lines.

Newport Beach, California

Hear when a new Moderate to Severe Glabellar Lines trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.